Novartis SA, Switzerland's second- largest drugmaker, said a patient died and another developed a serious infection in tests of its experimental multiple sclerosis treatment FTY720.
Read article at bloomberg.com
Showing posts with label treatment FTY720. Show all posts
Showing posts with label treatment FTY720. Show all posts
Thursday, June 12, 2008
Novartis says experimental multiple sclerosis treatment FTY720 is linked to death and infection
Posted by
Willow
at
4:40 pm
Labels: adverse side-effects, MS, multiple sclerosis, Novartis, treatment FTY720
Subscribe to:

